Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

Background: The aim of the analysis is to assess the efficiency of the allocation of economic resources related to the use of letermovir cytomegalovirus (CMV) prophylaxis in adult seropositive recipients (R+) patients receiving an allogenic hematopoietic stem cell transplantation (HSCT), compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Restelli, Umberto, Croce, Davide, Pacelli, Valeria, Ciceri, Fabio, Girmenia, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512572/
https://www.ncbi.nlm.nih.gov/pubmed/31190905
http://dx.doi.org/10.2147/IDR.S196282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512572/
https://www.ncbi.nlm.nih.gov/pubmed/31190905
http://dx.doi.org/10.2147/IDR.S196282

Ejemplares similares